← Back to All Filings

Teradyne Officer/Director Plans $161k Stock Sale (TER)

Medium SignificanceOctober 10, 2025 at 10:32:42 AM EDT

TERADYNE, INC

$TER144CIK: 0000097210

Subscribe to track TER

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Teradyne Officer/Director Plans $161k Stock Sale (TER)

Company: TERADYNE, INC (TER) Form: 144 | Filed: 2025-10-10 Significance: Medium

Insider: Smith Gregory Stephen Title: Officer | Relationship: Officer, Director

Transaction (Proposed Sale): • Type: Sale • Shares: 1,108 • Price: ~$145.24 • Value: $160,925.92 • Owned After: Not Disclosed

Key Insight: This is a notice of a proposed sale by a dual-role insider (Officer and Director). The sale appears to be executed under a pre-arranged 10b5-1 trading plan adopted in February 2025, suggesting it is a planned liquidity event rather than a reaction to new information.

Market Context: The shares were acquired via restricted stock vesting. The filing also discloses a pattern of similar-sized sales over the past three months, reinforcing the interpretation of a systematic, planned selling schedule.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: TERADYNE, INC (TER)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: An Officer and Director of Teradyne has filed a notice to sell 1,108 shares valued at approximately $161k. The sale is part of a pre-established 10b5-1 trading plan, mitigating concerns of it being a reaction to immediate negative news.
  • Market Impact: The market impact is expected to be neutral to slightly negative. The pre-planned nature of the sale and the relatively modest size should prevent significant downward pressure on the stock price.

Company Information

FieldValue
CompanyTERADYNE, INC
Ticker SymbolTER
CIK0000097210
IndustryINSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]

Insider Information

FieldValue
NameSmith Gregory Stephen
CIK0001666934
Title/PositionOfficer
RelationshipOfficer, Director

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-10-10 (Approximate Sale Date)
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved1,108
Price Per Share~$145.24 (Calculated from Aggregate Market Value)
Total Value$160,925.92
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Form 144 filings for sales under a 10b5-1 plan are common and generally viewed by the market as planned liquidity events for insiders. The shares originated from vested restricted stock, a form of compensation. This context suggests the sale is for personal financial management (e.g., diversification, tax obligations) rather than a lack of confidence in the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is insignificant compared to Teradyne's average daily trading volume.
  • Sentiment Indicator: Neutral. Sophisticated investors typically discount sales made under 10b5-1 plans. The consistent pattern of sales reported for the prior three months further supports this being a routine, scheduled transaction.

Investment Insights

Positive Market Indicators

  • The sale is being conducted under a 10b5-1 plan, which was adopted well in advance (February 2025), removing the element of surprise or speculation about timing.
  • The source of shares is vested compensation, a standard reason for insider selling.

Risk Factors

  • The seller holds a dual role as both an Officer and a Director, giving them significant insight into the company's operations and strategy.
  • The filing indicates a consistent pattern of selling over the past three months, which, if it continues or accelerates, could be perceived negatively over the long term.

Key Takeaways

  1. Planned Liquidity Event: This is a notice of a proposed sale, not a spontaneous decision. The 10b5-1 plan is the key context.
  2. Compensation-Related Sale: The shares were acquired as part of the insider's compensation package, making sales for liquidity and tax purposes a normal and expected activity.
  3. Pattern of Selling: The insider has been systematically selling shares, which is a data point to monitor over time but is not immediately alarming given the planned nature.

Contextual Analysis

Timing Significance

The filing date and approximate sale date are the same, indicating an immediate intention to sell. However, the decision to sell was effectively made when the 10b5-1 plan was adopted in February 2025.

Transaction Context

The filing explicitly notes a planAdoptionDate of February 4, 2025. This confirms the sale is pursuant to a Rule 10b5-1 trading plan. This rule provides an affirmative defense against insider trading allegations, as it allows insiders to set up a predetermined trading schedule when they are not in possession of material non-public information.

Company Context

Teradyne operates in the semiconductor test equipment industry. Analysis of this filing should be paired with an understanding of the current semiconductor cycle, recent company earnings reports, and forward guidance to place the insider's actions in a broader business context.

Risk Assessment

Risk Level: Low

Risk Factors

  • Insider Role: High-level insiders selling can sometimes be a negative signal, but this is heavily mitigated by the context.
  • Market Perception: While sophisticated investors understand 10b5-1 plans, retail investors may misinterpret any insider sale as a bearish signal.

Market Considerations

  • Sector Trends: The performance of the broader semiconductor and tech sectors will have a much larger impact on the stock price than this individual transaction.
  • Systematic Selling: The primary risk is not this single transaction, but what the continuation of this selling pattern might imply over many quarters.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-10 | Data source: SEC EDGAR

Topics:#Teradyne#TER#InsiderTrading#SECFiling#Form144#InsiderSell#StockMarket#Investing#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.